Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study by Handels, Ron L. H. et al.
 
 
 
Quality of Life, Care Resource Use, and Costs of
Dementia in 8 European Countries in a Cross-
Sectional Cohort of the Actifcare Study
Citation for published version (APA):
Handels, R. L. H., Skoldunger, A., Bieber, A., Edwards, R. T., Goncalves-Pereire, M., Hopper, L., Irving,
K., Jelley, H., Kerpershoek, L., Marques, M. J., Meyer, G., Michelet, M., Portolani, E., Rosvik, J., Selbaek,
G., Stephan, A., de Vugt, M., Wolfs, C., Woods, B., ... ActifCare Consortium (2018). Quality of Life, Care
Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the
Actifcare Study. Journal of Alzheimer's Disease, 66(3), 1027-1040. https://doi.org/10.3233/JAD-180275
Document status and date:
Published: 01/01/2018
DOI:
10.3233/JAD-180275
Document Version:
Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 05 Jan. 2021
Journal of Alzheimer’s Disease 66 (2018) 1027–1040
DOI 10.3233/JAD-180275
IOS Press
1027
Quality of Life, Care Resource Use,
and Costs of Dementia in 8 European
Countries in a Cross-Sectional Cohort
of the Actifcare Study
Ron L.H. Handelsa,b,∗, Anders Sköldungerb, Anja Biebere, Rhiannon Tudor Edwardsk,
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Abstract.
Background: With 10.5 million people with dementia in Europe and $301 billion associated costs, governments face
challenges organizing access to care.
Objective: To examine the costs related to formal and informal care use and quality of life for people with dementia in eight
European countries, and explore the association with unmet needs.
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Methods: Cross-sectional data from 451 persons with dementia and their informal caregivers of the Actifcare cohort study
were obtained. Formal and informal care use was multiplied by country specific unit prices of services. Needs were measured
using the CANE and health-related quality of life (HRQOL) of the person with dementia (both self- and proxy-rated) and
informal caregiver’s quality of life using EQ-5D-5L, ICECAP-O, DEMQOL-U, and CarerQol utility scores. The association
between costs and country, European region, and unmet needs was assessed using multi-level linear regression.
Results: Self-rated EQ-5D-5L utility score was higher than proxy-rated (0.84 and 0.71, respectively). Informal caregivers’
utility score was 0.84. Across eight countries annual mean costs of formal and informal care were approximately D 17,000.
Unmet needs were not associated with annual costs of care, nor with proxy-rated HRQOL, but were associated with self-rated
HRQOL.
Conclusion: We found varying relationships between unmet needs and quality of life, and no association between unmet
needs and care costs, although the results were sensitive to various factors. Future research should further investigate the
relation between unmet needs, quality of life and costs to generate a better understanding of the effects of (un)timely access
to care.
Keywords: Access to care, costs, dementia, health-economics, quality of life, unmet needs
INTRODUCTION
Dementia, caused by Alzheimer’s disease (AD) or
related diseases, forms a major health, social, and
economic global challenge of the 21st century. This
has been highlighted as a priority by the WHO [1] as
well as the European Parliament [2]. It is estimated
that 10.5 million people in Europe have dementia [3]
accounting for over 22% of the total number of people
with dementia worldwide. The total societal costs of
dementia in Europe in 2015 were estimated at $301
billion, of which $180 billion were costs of medi-
cal and social care and $121 billion were related to
informal care [3].
In recent decades, various national and inter-
national organizations and collaborations such as
Alzheimer’s Disease International and the ALCOVE
project have promoted timely recognition of demen-
tia [4]. One aim of timely recognition is to improve
access to services such as home care support that
could help to maintain independence and dignity.
People with dementia probably could stay at home
longer with their families if the right support was put
in place that addresses their needs. Most countries
acknowledge that this is important and have policies
to develop better home-based and community ser-
vices and reduce institutionalization [5]. Research
has revealed that people with dementia and their
informal caregivers are not receiving services of
the type and quality that they need, and that they
experience difficulties accessing and working with
community care services, even with a diagnosis of
dementia [6, 7]. This can put increased pressure on
people with dementia and their families which might
lead to admission to institutional care because the
appropriate support is not in place [8]. Thus, despite
the potential benefits of timely access to formal care
and the need for these services to support informal
caregivers, low rates of service use are still observed.
In addition, there is great diversity and inequity
among different health care and social care systems
related to dementia between and within individual
European countries [5, 9, 10]. The right to health care
is an essential element of the Universal Declaration of
Human Rights [11] and of the UN Convention on the
Rights of Persons with Disabilities [12]. It is widely
acknowledged that social and economic inequalities
in access to health care should be eliminated to meet
the needs of elderly [13]. Therefore, there is a need for
research-based studies to chart, analyze, and evaluate
the strengths and weaknesses of individual pathways
to care and infrastructures. The impact of dementia on
the population of Europe is of such a magnitude that
this problem must be addressed cooperatively across
European countries.
Demographic changes and an aging population
(and as a consequence, an increasing number of peo-
ple with dementia) means most countries in Europe
are facing great challenges in the current and future
long-term funding of care for elderly, and people with
dementia in particular. Due to the impact of resource
use and costs of dementia on health care and social
care systems in Europe, a proper understanding of
the costs and outcomes of formal and informal care
services utilization is fundamentally important for
raising awareness, achieving effective prioritization,
and focusing efforts to improve the lives of people
with dementia and their caregivers.
The overall aim of this study is to examine the costs
related to formal and informal care use and quality
R.L.H. Handels et al. / Costs and Outcomes Untimely Care 1029
of life for people with dementia in eight European
countries, and explore the association with unmet
needs.
METHODS
Design and participants
In the Actifcare (ACcess to TImely Formal care)
study [14], participants with dementia and their infor-
mal caregivers were recruited in 2014 and 2015
in a prospective longitudinal cohort (baseline, 6
months, and 12 months follow-up) in eight Euro-
pean countries: Germany (DE), Ireland (IE), Italy
(IT), the Netherlands (NL), Norway (NO), Portu-
gal (PT), Sweden (SE), and United Kingdom (UK).
Measurement instrument scores (reflecting socio-
demographics, cognition, care use, quality of life,
quality of relationship, capability, (un)met needs,
neuropsychiatric symptoms, comorbidity, activities
of daily life for the people with dementia, and
social isolation, quality of relationship, quality of life,
anxiety and depression, perseverance time, stress,
capability, control, sense of coherence, and personal
and social resources for the informal carers) were
obtained by a personal interview between the per-
son with dementia, the informal caregiver and the
researcher, and part of them were used for this study.
In every country ethical approval was obtained sep-
arately and written informed consent was attained
for both the person with dementia and the caregiver.
Eligibility criteria were: 1) Diagnosis of dementia
by DSM IV TR; 2) Clinical dementia rating score
mild or moderate or Mini-Mental State Examination
(MMSE) ≤24; 3) Not receiving regular assistance
from a paid worker with personal care on account
of his/her dementia; 4) Additional assistance with
personal care within 1 year is likely judged by a
healthcare professional; 5) An informal caregiver
willing to participate; 6) Able to complete the assess-
ments; 7) Not been in care home or nursing home
during the previous 6 months; 8) No alcohol-related
dementia or Huntington’s disease. For this study,
cross-sectional data from the baseline assessment has
been used.
Clinical measurement instruments and unmet
needs
We measured dementia severity and vari-
ous domains of symptoms using the following
instruments: MMSE [15] to reflect cognitive func-
tioning; the Lawton instrumental activities of daily
living scale (IADLS) [16] and the Physical Self-
Maintenance Scale (PSMS) [16] to rate activities
of daily living; and the Neuropsychiatric Inventory
(NPI-Q) [17] to reflect neuropsychiatric symptoms.
We used sum scores of these scales in the analysis.
Needs were measured by the Camberwell Assess-
ment of Need for the Elderly scale (CANE) [18] and
scored by the researcher taking into account both
the perspectives of the person with dementia and the
informal caregiver. This interview-based question-
naire has been designed to map the needs (present
and, if so, met or unmet) and amount of help (received
and needed) for older people over 24 categories
covering psychological, physical and environmental
domains. A total sum of met needs and a total sum of
unmet needs was generated.
Health-related quality of life, wellbeing, and
utility
Quality of life and wellbeing measures relevant
for health-economic evaluation included the EQ-
5D-5L, ICECAP-O, DEMQOL-U, and CarerQol, as
they reflect the general health-related, wellbeing cov-
ering dimensions ‘beyond health’, disease specific
and caregiver-related quality of life respectively, and
enable the calculation of a tariff-based utility score.
The EQ-5D-5L, ICECAP-O, and DEMQOL-U of the
person with dementia were all self-rated and proxy-
rated by the informal caregiver.
Index values were available for the EQ-5D-5L
(among the participating countries in Actifcare: UK
[19, 20], NL [21], ongoing for DE and PT [22],
and crosswalk set for DE, NL, and UK [23]),
the ICECAP-O (UK [24]), the DEMQOL-U and
DEMQOL-PROXY-U (UK [25, 26] both general
population as well as dementia-specific population),
and the CarerQol (NL [27]). Due to the lack of
index values for the countries included in our Act-
ifcare study, we used the UK index values for each
country in our study. In addition, the Visual Ana-
logue Scale (VAS) of the CarerQol and the EQ-5D-5L
were used. See notes Table 2 for score ranges and
interpretation.
Resource use and costing formal and informal
care
The Resource Utilization in Dementia (RUD)
instrument [28] was used to collect data on resource
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use consumed by both the person with dementia
and the informal caregiver in terms of frequency
and intensity (number of visits or time measured in
days, visits or hours) from a societal perspective. This
included living accommodation (person with demen-
tia), admission to hospital (both person with dementia
and informal caregiver), hospital emergency room
(both), care professionals (both), services (nursing,
home care, food delivery, day care, transportation
and other) (person with dementia), informal care
and absenteeism from work / income losses associ-
ated with caring for person with dementia (informal
caregiver). Resource use was measured over a recall
period of 30 days at baseline. The RUD instrument
uses estimates of the amount of informal care received
in three domains: personal Activities of Daily Liv-
ing (ADL), instrumental ADL and supervision (i.e.,
prevent dangerous events). The RUD instrument has
been widely used and comprehensively validated
[29, 30].
To calculate the resource use related costs,
frequencies of resource use were multiplied by
unit prices. Prices were based on specific national
sources, publications with multi-country price
estimates [31, 32], and assumptions based on
authors’ opinion (see Supplementary Table 1), and
transformed to Euros reflecting the year 2015. Costs
were linearly extrapolated to a 1-year period to
enable comparison with other studies. Informal care
was valued according to the opportunity cost of
which the hourly rate was reflected by the mean
wage derived from http://ec.europa.eu/eurostat for
each country in our study. This was only applied to
personal ADL and instrumental ADL, which reflect
active caring time. To reflect the mix of retired and
non-retired informal caregivers 35% of the country
specific mean wage was used [33].
Statistical analysis
Summary statistics were provided for demograph-
ics and outcomes in terms of disease severity, quality
of life, resource use, and corresponding costs of the
consumed care resources of the person with demen-
tia and their informal caregivers. For resource use,
both the percentage users and the mean frequencies of
resource use among the users were estimated. Costs
were bootstrapped using 5000 replicates and the 2.5th
and 97.5th percentile of the mean was estimated using
the statistical software R3.3.1 [34].
Missing demographic, clinical, HRQOL, and
care usage were item-wise deleted (e.g., when a
participant had missing visits to a neurologist, this
participant was omitted for the calculation of mean
care professional usage but not for mean accommo-
dation). For the calculation of costs, frequencies of
resource use were imputed across the entire dataset
by multiple imputation using the STATA13 chained
equations and predictive mean matching command to
construct an imputation model with age and gender of
both the person with dementia and informal caregiver,
MMSE, IADLS, PSMS and NPI, CANE, quality of
life as well as RUD items as predictor variables. Ten
imputed datasets were generated. The mean of all 10
imputed datasets was used only for describing the
costs by country and category of number of unmet
needs (see below).
Country differences regarding demographics, dis-
ease severity and quality of life were assessed using
ANOVA and Chi-square tests. A multivariate regres-
sion model was used to assess cost differences
between countries and country regions (Northern:
Norway and Sweden; Western: Germany, Ireland,
Netherlands, and United Kingdom; Southern: Italy
and Portugal). To ensure the regression assumption of
linearity, costs were transformed using the natural log
with a data-driven optimal correction factor. These
were ln(costs + 1087) when using country-specific
unit prices and ln(costs + 1621) when using mean unit
prices. Person with dementia demographic (age and
gender) and disease severity (MMSE, IADLS, PSMS,
and NPI) variables were included in both models as
covariates.
The association between natural log transformed
costs and unmet needs was assessed using regres-
sion. The number of unmet needs according to
the CANE instrument was categorized into 0, 1–2,
and more than 2 based on expert opinion (AW,
AS, RH). A mixed model was used with country
as random factor to adjust for country differ-
ences. The number of needs was considered a
confounder and was therefore included as a covari-
ate. It was also assumed to reflect the effects of
age, comorbidities and functional dependency. Sim-
ilarly, the association between categorized unmet
needs and both self- and proxy-rated EQ-5D-5L was
assessed. In all analyses, p < 0.05 was considered
significant.
Sensitivity analysis
We explored various alternative options in sen-
sitivity analyses. The mean of the country-specific
unit prices was used to exclude any differences
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Table 1
Sample demographic and clinical characteristics.
Norway Sweden Germany Ireland Netherlands United Italy Portugal All
Kingdom
(n = 60) (n = 50) (n = 54) (n = 43) (n = 51) (n = 76) (n = 53) (n = 66) (n = 451)
North North West West West West South South
Person with dementia
Age∗ 78 (7) 80 (7) 77 (9) 74 (9) 76 (8) 79 (8) 79 (8) 77 (6) 78 (8)
Female gender∗ 60% 52% 42% 51% 57% 43% 70% 62% 55%
Education (years)∗ 11 (3) 9 (3) 12 (3) 12 (4) 11 (4) 11 (2) 7 (4) 6 (6) 10 (4)
Marital status
Married 70% 72% 73% 67% 78% 48% 58% 76% 69%
Widowed 20% 21% 21% 28% 16% 34% 40% 18% 24%
Other 10% 7% 6% 5% 6% 18% 2% 6% 7%
Lives in own home∗ 95% 99% 98% 100% 94% 100% 91% 82% 94%
Lives together with carer∗ 73% 82% 77% 58% 80% 52% 55% 85% 72%
Clinical characteristics person with dementia
MMSE (0–30)∗ 19.1 (4.9) 20.4 (4.4) 20.2 (5.9) 20.3 (5.4) 19.8 (4.3) 18.8 (5.4) 16.9 (3.7) 17.8 (4.8) 19.0 (5.0)
IADLS (0–8)∗ 4.2 (1.8) 3.0 (2.0) 3.3 (2.0) 3.4 (2.6) 3.9 (1.7) 3.0 (1.7) 3.0 (1.8) 3.7 (2.0) 3.4 (2.0)
PSMS (0–6)∗ 4.5 (1.3) 4.0 (1.8) 3.2 (2.1) 3.4 (2.0) 4.1 (1.8) 3.4 (1.8) 2.8 (1.8) 3.7 (2.0) 3.6 (1.9)
NPI (0–30)∗ 8.8 (5.1) 5.6 (4.4) 6.1 (4.7) 8.9 (5.5) 9.1 (6.5) 7.9 (5.5) 8.7 (5.8) 6.8 (5.5) 7.7 (5.5)
CANE met needs (0–24)∗ 8.6 (2.3) 4.5 (2.1) 10.0 (4.5) 8.3 (3.6) 7.2 (2.5) 9.2 (3.4) 9.0 (2.0) 8.2 (2.8) 8.2 (3.3)
CANE unmet needs (0–24)∗ 2.2 (1.5) 0.1 (0.6) 1.4 (2.0) 3.3 (2.3) 2.6 (2.5) 1.7 (1.7) 1.7 (1.9) 1.2 (1.7) 1.8 (2.0)
Informal caregiver
Age∗ 70 (13) 67 (12) 69 (12) 58 (15) 69 (9) 70 (10) 60 (13) 65 (15) 66 (13)
Female gender 58% 58% 73% 77% 55% 72% 72% 67% 67%
Education (years)∗ 12 (4) 11 (3) 14 (4) 15 (4) 12 (3) 12 (3) 11 (4) 9 (6) 12 (4)
Marital status∗
Single/widowed 8% 8% 10% 16% 10% 14% 15% 14% 12%
Married/partnership/co-habiting 92% 92% 88% 84% 90% 86% 85% 86% 88%
Relation to person with dementia∗
Spouse/partner 73% 76% 75% 53% 75% 52% 38% 61% 64%
Son/daughter (in law) 25% 22% 21% 42% 20% 40% 57% 35% 32%
Other 2% 1% 4% 5% 6% 8% 6% 5% 4%
CANE, Camberwell Assessment of Need for the Elderly; IADLS, instrumental activities of daily living scale; MMSE, Mini-Mental State
Examination; NPI, neuropsychiatric inventory; PSMS, Physical Self-Maintenance scale. The range (best possible score underlined) of the
MMSE is 0 to 30, IADLS 0 to 8, PSMS 0 to 6, NPI 0 to 30, CANE met needs 0 to 24, and CANE unmet needs 0 to 24. ∗p-value <0.05 for
overall country-differences.
between countries in how the unit price was build-up.
In two other options, the price from the coun-
try with the lowest (Italy) and highest (Norway)
mean price was applied to all countries. For infor-
mal care on personal ADL and instrumental ADL,
a proxy good cost unit price was used reflecting
the mean wage for a person in the social care sec-
tor (also known as the replacement cost approach).
Furthermore, the costs of informal care supervision
were included in an option by applying the same
unit prices as for personal ADL and instrumental
ADL. Two imputation options of case-wise dele-
tion and imputation with 0 were applied on resource
use.
The regression analyses on costs were alternatively
run using mean unit prices instead of country-specific
unit prices. As an alternative to categorizing the num-
ber of unmet needs, it was included in the analysis as
a continuous measure in both the costs and HRQOL
analyses.
RESULTS
In total 451 people with dementia and their infor-
mal caregivers (dyads) participated in the Actifcare
study and were eligible for these analyses. The mean
age of people with dementia was 78 (SD: 8) and
55% were female (see Table 1). Almost all (94%)
lived at home and a few in non-dementia-specific
intermediate forms of accommodation, with a large
proportion living with their informal caregiver (72%).
Their mean MMSE was 19.0 (SD: 5.0) reflecting
a cognitive deficit in the mild to moderate demen-
tia range. The mean age of informal caregivers was
66 (SD: 13) and they were mainly spouses/partners
(64%) or sons/daughters (32%) of the person with
dementia. All demographic characteristics differed
significantly between countries, except for the gender
of the informal caregiver (see Table 1). The missing
data for each of the scales was less than 8% (see
Supplementary Table 2).
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Table 3
Mean (and standard deviation or 2.5 and 97.5 percentile bootstrap interval) of demographic, quality of life and costs by unmet needs (societal
costs in Euro (2015) of 30-day resource use prior to the baseline assessment up scaled to 1-year; imputed data)
No unmet 1 or 2 unmet 3 or more unmet All
needs (n = 156) needs (n = 162) unmet needs (n = 133)
Person with dementia
Age 78 (7) 77 (8) 78 (9) 78 (8)
Female gender 52% 59% 53% 55%
Lives together with caregiver 72% 73% 70% 72%
Clinical characteristics person with dementia
MMSE (0–30) 19.3 (4.8) 18.4 (5.2) 19.1 (5.1) 18.9 (5.1)
IADLS (0–8) 3.5 (2.0) 3.6 (2.0) 3.2 (2.0) 3.4 (2.0)
PSMS (0–6) 3.8 (1.9) 3.8 (1.8) 3.4 (2.0) 3.7 (1.9)
NPI (0–30) 5.7 (4.4) 7.8 (5.4) 10.1 (6.0) 7.8 (5.6)
CANE met needs (0–24) 7.7 (3.8) 8.8 (2.9) 7.7 (2.9) 8.1 (3.3)
CANE unmet needs (0–24) 0.0 (0.0) 1.4 (0.5) 4.5 (1.9) 1.8 (2.1)
Informal caregiver
Age 68 (13) 66 (13) 66 (14) 66 (13)
Female gender 66% 67% 67% 67%
Person with dementia
EQ-5D-5L utility (S)∗ 0.83 (0.16) 0.88 (0.13) 0.81 (0.19) 0.84 (0.16)
EQ-5D-5L utility (P)∗ 0.72 (0.20) 0.75 (0.19) 0.68 (0.20) 0.72 (0.20)
EQ-5D VAS (S) 72 (18) 74 (19) 71 (20) 72 (19)
EQ-5D VAS (P) 62 (19) 63 (20) 58 (20) 61 (20)
ICECAP-O utility (S)∗ 0.83 (0.12) 0.86 (0.14) 0.79 (0.18) 0.83 (0.15)
ICECAP-O utility (P)∗ 0.71 (0.17) 0.72 (0.15) 0.65 (0.18) 0.69 (0.17)
DEMQOL-U utility (S)∗ 0.89 (0.07) 0.88 (0.09) 0.85 (0.13) 0.87 (0.10)
DEMQOL-U utility (P) 0.75 (0.13) 0.74 (0.13) 0.72 (0.13) 0.74 (0.13)
Informal caregiver
EQ-5D-5L utility 0.84 (0.15) 0.85 (0.18) 0.82 (0.18) 0.84 (0.17)
EQ-5D VAS 72 (17) 73 (19) 70 (19) 72 (18)
ICECAP-O utility∗ 0.79 (0.15) 0.80 (0.14) 0.76 (0.17) 0.78 (0.16)
CarerQol utility∗ 0.79 (0.15) 0.77 (0.17) 0.72 (0.17) 0.76 (0.17)
Person with dementia
Accommodation1 0 (0–0) 146 (97–199) 1,241 (870–1640) 417 (304–539)
Hospital admission and emergency 1,129 (862–1417) 550 (379–737) 2,948 (1660–4360) 1,456 (1078–1900)
Care professional2 1,432 (1354–1515) 992 (936–1047) 991 (920–1062) 1,144 (1104–1186)
Services3 2,585 (2187–3011) 2,195 (1876–2556) 1,315 (1137–1501) 2,071 (1873–2262)
Informal caregiver
Informal care 8,604 (8156–9073) 9,425 (8996–9879) 10,636 (10092–11171) 9,497 (9227–9769)
Hospital admission and emergency 737 (330–1225) 552 (340–818) 1,929 (1001–2980) 1,021 (694–1377)
Care professionals2 676 (617–738) 700 (634–766) 1,007 (913–1111) 782 (739–828)
Productivity losses 1,142 (803–1506) 536 (389–706) 1,083 (844–1342) 907 (755–1065)
Total 16,305 (15383–17314) 15,095 (14426–15750) 21,151 (19477–23030) 17,296 (16634–18004)
P, proxy-rated; S, self-rated; VAS, visual analogue scale.
The utility ranges are 0-1, EQ-5D-VAS is 0-100 and the CarerQol VAS is 0-10, with higher estimate reflecting a better condition.
∗p-value < 0.05.
1Accommodation response options included accommodation in own home, intermediate, dementia specific, long-term institutional, and
other (see Supplementary Table 3).
2Professional response options included general practitioner, geriatrician, neurologist, psychiatrist, physiotherapist, occupational therapist,
social worker, psychologist, and other.
3Services response options included district nurse, home aid, food delivery, day care, transportation, and other (see Supplementary Table 3).
Mean quality of life and wellbeing scores are pre-
sented in Table 2. The mean health-related quality of
life of the people with dementia was 0.84 (self-rated)
and 0.71 (proxy-rated). A higher self-rated score was
also observed for the EQ-5D VAS (72 versus 61),
wellbeing measured by the ICECAP-O (0.82 versus
0.69 on a 0–1 scale), and DEMQOL-U (0.87 ver-
sus 0.74). Paired t-tests found significant differences
for all self- and proxy ratings. Informal caregivers on
average scored their own health-related quality of life
0.84, wellbeing 0.78, and CarerQol 0.76. All except
the informal caregiver’s EQ-5D-5L utility score sig-
nificantly differed between countries. Person with
dementia self-reported quality of life (excluding EQ-
5D VAS) significantly differed by reported unmet
need; those having 3 or more unmet needs reported
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Fig. 1. Mean annual societal costs in Euro (2015).
significantly lower quality of life. These differences
were, however, small (see Table 3). There was a
similar pattern for the proxy ratings and the carer
self-report, although fewer of the differences were
significant.
Extrapolated annual mean costs related to resource
use were D 17,296 across countries. About half of
these costs were related to informal care (D 9,497).
Highest total costs occurred in Ireland (D 23,737) and
lowest in Portugal (D 6,222) (see Fig. 1 and Table 4).
Costs relating to accommodation were highest in the
Netherlands, and Ireland had the highest costs for
hospital admission and emergency for participants.
Portugal had low informal care costs, which was
mainly related to the low unit price as resource use
was near the mean usage in the whole sample across
eight countries. Supplementary Table 3 provides an
overview of the mean reported resources used in the
30 days before the baseline assessment.
Transformed costs significantly differed between
countries (p < 0.001) as well as between country
regions (p < 0.001) after correcting for participants’
demographic and disease severity characteristics.
Categorized unmet needs (see Table 3) were
not significantly associated with transformed costs
(p = 0.180), were also not significantly related to
the proxy-rated EQ-5D-5L utility score of the per-
son with dementia (p = 0.426), but were significantly
related to the self-rated EQ-5D-5L (p = 0.009).
Sensitivity analysis
Sensitivity analysis showed a variation in mean
total cost of service use (formal and informal care)
when relying on different assumptions regarding unit
prices, cost categories and handling missing data (see
Supplementary Table 4). Although mean total cost
of service use between countries varied, the impact
of using mean of all country unit prices instead of
country-specific unit prices was relatively small. The
value assigned to informal care had a large impact
on mean total cost of formal and informal care. The
imputation method case-wise deletion affected the
mean total costs of Germany. This can be explained
by the fact that a large proportion of the German par-
ticipants had one or only a few missing responses to
one of the various items of the care use questionnaire,
requiring the case-wise deleting of these participants
from this particular scenario of the sensitivity anal-
ysis (opposite to a relatively small proportion of
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participants with missing responses in the other coun-
try samples) (see Supplementary Table 2).
Country differences in costs were also significant
when relying on mean unit prices (p = 0.021) but
country region differences were not (p = 0.603).
Regarding unmet needs, they were significant
when relying on mean unit prices (p = 0.028). Unmet
needs included on a continuous scale were not sig-
nificant when relying on country-specific unit prices
(p = 0.053) but were when relying on mean unit prices
(p = 0.014). Unmet needs on a continuous scale were
not significantly related both to proxy- (p < 0.129) or
self-rated (p < 0.072) quality of life. Residuals in the
analyses were good (costs) to moderately (quality of
life) normally distributed.
DISCUSSION
Summary of findings
The annual mean costs in eight countries in North-
ern, Western, and Southern European were D 17,296
in a convenience sample of people with dementia
and their informal caregivers, but it differed between
countries. The main cost driver was informal care
(55% of the total costs). Persons with dementia rated
their health-related quality of life higher than their
proxies. Unmet needs were not associated to trans-
formed costs or health-related quality of life rated by
the informal caregivers of the people with dementia.
The costs differed between countries in terms of
the amount of care provided, its economic value
reflected by the unit price and its corresponding costs.
Although the included countries in this study reflect
European welfare state systems, there are neverthe-
less differences in how care is organized and financed.
The costs and outcomes that are presented seem to
reflect the expected differences in terms of high con-
sumption of formal care in Northern and Western
Europe, but not in terms of informal care. Compared
to all countries, mean usage, Portugal and Italy had
slightly lower and slightly higher informal care use
respectively. In Portugal, this could be explained by
the low unit price as well as the reported use of the
services of a “housekeeper” (mean 17.9 hours in 30
days), which may have substituted or prevented infor-
mal care in this sample. Some differences between the
division of care over the various care sectors might be
due to outliers, as for example in Ireland one person
reported all days of the recall period spent in a hospi-
tal corresponding to an impact of D 6,667 on the mean
total costs in Ireland (D 530 on the mean total costs
of all countries; this is on the border of the 2.5 and
97.5 percentile bootstrap interval). The case was not
excluded since it was a justified observation and was
therefore explored in the sensitivity analyses. Also,
unobserved demographic or disease severity charac-
teristics that are associated to costs or HRQOL could
have differed between the country-specific samples,
which could have biased the country differences.
Mean annual care costs of AD-type dementia were
estimated D 6,063 in Northern Europe, D 8,279 in
Western Europe, and D 7,049 in Southern Europe in
the ICTUS study [35]. Our estimates were higher and
could mainly be explained by the exclusion of med-
ical care consumption by the informal caregiver, the
difference in population due to recently diagnosed
patients at a memory clinic (with a large proportion
of very mild AD), and the lower unit price applied
to informal care in the ICTUS study. Similar to the
ICTUS study, we observed lower medical care in
Southern Europe, but we did not observe higher infor-
mal care for the possible reasons explained earlier.
The total annual costs in a subsample of mild and
moderate AD-type dementia in the GERAS study
[36] were D 20,376 in three Western European coun-
tries. This was similar to our findings as well as the
proportion of costs in the costs categories in the over-
lapping countries Germany and United Kingdom.
The sample characteristics in terms of demograph-
ics and disease severity also were similar, as well as
the unit prices and included costs components. How-
ever, specific to this study were two of the inclusion
criteria (exclusion of persons receiving regular paid
assistance; including persons who will likely receive
formal personal care within 1 year), of which the first
could have resulted in a lower estimate and the sec-
ond in a higher estimate of care use compared to the
typical studied secondary memory clinic population
with a recent diagnosis of AD-type dementia.
Compared with Parkinson’s disease, our sample
reflects a relatively large proportion of costs related to
non-medical costs (informal care and social services)
and a relatively small proportion of direct medical
costs, which has been more equally distributed in
Parkinson’s disease [37–39].
The proxy-rated person with dementia’s quality of
life was lower than the person with dementia’s self-
rating (with somewhat higher proportions of missing
data for the self-rated observations, see Supplemen-
tary Table 2). This has been shown earlier [40] and
highlights the issue of the rater’s perspective. Peo-
ple with mild and moderate dementia can to a great
extent express their views. However, as the disease
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progresses, awareness of memory and functional lim-
itations decreases [41]. Awareness was also found to
be associated with sociodemographic characteristics
and the relation between the person with dementia
and the informal caregiver [42]. If a person with
dementia rates aspects of quality of life as “good or
high level” (domains of quality of life may include
cognitive but also functional aspects) but a proxy has
a different perspective and therefore rates them as
“worse or low level”, one could wonder which per-
spective (patient, proxy or presenting both) best fits
the research question of a particular study. Various
studies have indicated differences between both per-
spectives [43], which suggested further research is
needed.
Costs could not be explained by the number of
unmet needs in the main analysis, for which vari-
ous explanations are plausible. Costs were based on
care usage in the 30-day period before the obser-
vation of unmet needs. Although a relatively short
time period, care use could have affected needs. Also,
the use of medical and informal care could not have
been a consequence of the unmet needs (e.g., care
related to crisis situations because a lack of super-
vision or day care activities). The association also
seemed to be dependent on the unit price, as the sen-
sitivity analyses indicated a significant association
when relying on mean unit prices. The analysis was,
however, subject to limited power since at baseline
of the Actifcare study persons using dementia-related
formal care were excluded from participation, leaving
limited possibilities to observe so-called dementia-
related consequential care. The impact of unmet
needs on service use would be expected to emerge in
longitudinal analyses, especially in situations where
informal care is not successful in meeting the unmet
need. HRQOL was also not related to unmet needs,
although these results were dependent on who rated
the HRQOL (sensitive to proxy- versus self-rating).
Also, it unexpectedly increased from 0 to 1 or 2
unmet needs (+0.03) and decreased from 1 or 2 to
3 or more (–0.07). Subgroup differences in terms of
demographics and the particular needs that are unmet
could be confounding factors in this association, or
there could be a tipping point where unmet needs
begin to impact on HRQOL.
Limitations
For the regression analysis on costs predicted by
unmet needs, the care-related costs were observed
earlier in time than the unmet needs. The care use in
this period could have affected the needs. However,
given the relative short time period of 30 days and
our expectation that care use and needs are relatively
stable over this time period, we did not expect this to
have a significant impact on the results.
This analysis was based on a specific sample
of home-dwelling persons with mild or moderate
dementia. The people with dementia in this study
were living at home at baseline and were selected
based on their probability of needing formal care
within 1 year. They do not represent the general pop-
ulation with dementia and thus it is not possible to
generalize our results to reflect the cost of illness
of the national dementia population in each country.
The representativeness was further limited by the rel-
atively small country-specific sample sizes (ranging
from 43 to 76), which made them prone to coinciden-
tal effects on the inclusion. The descriptive statistics
were not adjusted for possible country differences and
should therefore be interpreted with caution. Also,
the imputation procedure did not adjust for country
differences. Although alternative imputation strate-
gies have been explored and did not result in relevant
differences in costs, it could have had an impact on
the results. Countries in Eastern Europe were not
included in the Actifcare project. These countries can
be expected to differ from the other regions.
Costs related to medication use were not included
and therefore the total care costs are underestimated.
However, these costs were likely to be small as they
reflected less than 10% of the total costs in the
ICTUS study [35]. The costs due to productivity loss
were partly double-counted with the costs related to
hours providing informal care, which slightly over-
estimated the total costs. Although rescaling costs
observed over a 30-day period to 1 year does not
affect the significance in the regression analysis, these
might not reflect the actual 1-year costs.
The economic valuing of informal care is a com-
plicated and controversial topic [44]. A standard is
completely lacking and thus transparency regarding
how informal care is quantified and valued is crucial,
as is varying uncertainties in a sensitivity analysis.
Country-specific prices were likely subject to
methodological differences. Among them was a dif-
ference in how the price was built up (e.g., hotel costs
in- or excluded in hospital care price). The location at
which prices are published varied and the language
was often non-English, which increased the likeli-
hood of missing important sources. Some sources
reported a price per hospital or care home admis-
sion without clear information on the mean days of
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an admission, making it difficult to transform it into
the format of the RUD questionnaire. There were also
discrepancies between the designation or description
of the care type by the RUD questionnaire and by the
source reporting the unit price (e.g., prices reported
for diagnosis-related-groups), as well as differences
in the year at which a price was derived (see Supple-
mentary Tables 1 and 5 for details). These limitations
strongly indicate the need to harmonize the methods
to calculate care unit prices in Europe and make them
easily accessible (such as aimed by the PECUNIA
project, http://www.pecunia-project.eu).
Some of the uncertainties due to the limitations
were taken into account in the sensitivity analysis to
reflect their impact on the total costs and results of the
analyses. In explorative post-hoc analyses, the cut-off
for low and high numbers of unmet needs was ranged
between 1 and 10 but did not result in any significant
relation between categorized unmet needs and care
costs. However, various results were significant for
p < 0.20 and omitting participants with high number
of unmet needs (more than 10) resulted in a significant
relation between unmet needs and costs as well as
when included on a continuous scale, indicating this
relation was sensitive to the method and unstable,
and therewith subject for future research. The post-
hoc analysis and sensitivity analysis were subject to
multiple testing for which was not adjusted. They
should be considered as explorative results.
Recommendations for future research
The sensitivity of the associations between unmet
needs and costs, and unmet needs and HRQOL to
the unit prices, rater and outcome scale indicates
there might be a potential for efforts on improving
the access to care to improve the quality of life for
people with dementia and reduce their costs. How-
ever, further research into this topic is crucial to
explore subgroups with a strong association between
unmet needs and costs or unmet needs and HRQOL
(potentially a combination of the living situation and
presence of behavioral or cognitive symptoms). Such
knowledge could help to develop person-tailored
interventions that can be applied to a subgroup with
a high potential for improving their HRQOL.
In addition, longitudinal data is important to reflect
upon the timing of care (longer enduring unmet needs
might have a larger impact on care use and HRQOL)
and the type of need (unmet need on neuropsychi-
atric symptoms might weigh heavier on for example
informal caregiver time and HRQOL than an unmet
need on compliance to medication). Furthermore,
details on the degree of unmet needs and the pro-
portion of a need already being met by informal
care could be used to increase our understanding of
the effects of unmet needs on costs and HRQOL.
The potential effect is large as mean annual costs
have been estimated to be D 29,148 and D 53,892
in a population consuming professional home care
and institutional long-term nursing respectively [45],
which is significantly higher than the costs estimated
in our population of persons not consuming profes-
sional care. These topics, however, fell outside the
scope of this analysis and are topic of research within
the Actifcare study [14].
Conclusion
Our eight country European study, one of the
largest comparative studies in dementia care, did not
find a relationship between unmet needs and qual-
ity of life, and not between unmet needs and care
costs, although the results were sensitive to various
factors. Given the interaction between formal and
informal care future research should unravel the rela-
tionship between unmet needs, quality of life and
costs to generate a better understanding of the effects
of (un)timely access to care.
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